Bacterial metabolism of synthetic steroids across ecosystems reveals diverse biotransformation products, reactions, and enzymes
This study systematically maps the diverse biotransformation of 22 synthetic and natural steroids across 12 bacterial species, revealing novel enzymes, aerobic side-chain cleavage mechanisms, and cooperative cross-feeding interactions that collectively define the molecular basis of microbial steroid metabolism in gut and environmental ecosystems.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Steroid drugs are among the most common medicines in the world, used to treat everything from severe inflammation to hormonal imbalances. Many of these are synthetic, meaning scientists have tweaked their chemical structures to make them more potent and longer-lasting in the human body. However, once these drugs leave the body, they do not simply vanish. They enter the environment through wastewater, where they can linger and disrupt the development of fish and amphibians. The fate of these chemicals depends heavily on the microscopic life that surrounds them. Bacteria, the single-celled organisms that inhabit our guts and the soil, are nature's primary recyclers. They possess the ability to break down complex molecules, often changing them into different substances. For decades, scientists have known that bacteria can alter steroids, but the full scope of this activity has remained a mystery. We did not know which specific bacteria were involved, what chemical changes they were making, or how different species might work together to dismantle these stubborn drugs.
A team of researchers at the European Molecular Biology Laboratory set out to map this hidden world of microbial metabolism. They focused on twenty-two different steroid compounds, ranging from common corticosteroids used for inflammation to synthetic estrogens and progestogens. To see how these drugs were transformed, they tested them against a panel of twelve different bacterial species. Eight of these bacteria were isolated from the human gut, while four were taken from the environment. The team incubated each drug with each bacterium, creating hundreds of unique combinations, and then used advanced mass spectrometry to track exactly what happened to the molecules over time. This technique allowed them to detect even tiny amounts of new chemical structures that appeared as the bacteria ate the drugs.
The results revealed a much more diverse and active landscape than previously understood. The bacteria did not just break the drugs down into harmless waste; they performed a wide variety of chemical surgeries. Some bacteria stripped away ester groups, effectively activating prodrugs that were designed to be inert until they reached the body. Others removed oxygen or added hydrogen, changing the drug's shape and function. One of the most significant discoveries involved a specific environmental bacterium called Sphingobium herbicidovorans. This microbe demonstrated the ability to cleave the side chain of a steroid molecule, a reaction that effectively chops off a large portion of the drug's structure. Until now, scientists believed this specific type of cutting, known as desmolase activity, was a skill possessed only by anaerobic bacteria living in the gut, which thrive without oxygen. Finding this same ability in an aerobic environmental bacterium, which requires oxygen to survive, was a major surprise. It suggests that the capacity to dismantle these complex molecules is far more widespread in nature than previously thought.
To understand how this was possible, the researchers needed to find the specific tools the bacteria were using. They combined computer analysis of genetic sequences with a "gain-of-function" screen, a method where they inserted random pieces of the environmental bacterium's DNA into a different, easier-to-study bacterium to see if it gained new abilities. They also looked at which proteins the bacteria produced when exposed to steroids. Through this multi-pronged approach, they identified six distinct enzymes responsible for the transformations. One enzyme was found to cut the side chain of the steroid, while others were responsible for hydrolysis, oxidation, and reduction. This work provided a direct link between the genetic instructions in the bacteria and the specific chemical changes they caused, moving the field from observing what happens to understanding exactly how it happens.
The study also highlighted that bacteria do not always work alone. In the wild, they live in complex communities where the waste of one becomes the food of another. The researchers tested this by simulating a cross-feeding scenario. They found that one bacterium could partially break down a steroid drug, creating a new intermediate molecule that another bacterium could then finish processing. For example, a gut bacterium could strip an ester group from a drug, and then an environmental bacterium could take that modified product and cleave its side chain. This cooperative metabolism means that the final fate of a steroid drug depends on the specific mix of bacteria present in a given environment. If a community lacks the right partner, the drug might get stuck in a partially transformed state, potentially altering its environmental impact.
By connecting the specific enzymes to the chemical reactions and the community interactions, this research provides a clear molecular map of how synthetic steroids are handled by the microbial world. It shows that the breakdown of these persistent pollutants is not a single event but a chain of specialized steps performed by different organisms. The discovery of new enzymes, particularly the aerobic side-chain cleavage, opens up possibilities for using these biological tools to clean up contaminated water or to better predict how these drugs behave in the environment. The study confirms that the microbial world is a highly sophisticated chemical factory, capable of reshaping the most resilient synthetic molecules through a combination of individual specialization and collective cooperation.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.